Daewoong Pharmaceutical opens Chinese laboratory

Published: 16-Dec-2014
Research & Development

Now established in Beijing and Shenyang


Korean drug company Daewoong Pharmaceutical has taken a step towards establishing a global network with its recently built Daewoong Pharmaceutical Liaoning laboratory in China becoming operational.

The newly built lab, located in the Benxi Economic Development Zone near Shenyang, will develop oral solution products and solid formulations for Chinese consumers. The lab is under Liaoning Baifeng, a Shenyang-based drug manufacturer acquired by the Korean company in August 2013.

Daewoong Pharmaceuticals now has a corporate body and offices in Beijing and factories and labs in Shenyang. With these establishments, the company plans to reach sales revenue of US$463.4m within China by 2020.

The drug lab adopts an open collaboration strategy that encourages collaboration with major institutions in the three Northeast Provinces in China, such as the local colleges of pharmacy, research centres and other pharmaceutical companies in drug technologies and research.

  • Companies:
  • Daewoong Pharmaceutical
See more

You may also like

Research & Development

AffyXell expands partnership with GenScript ProBio

Read more
As part of the strategic alliance, GenScript has committed to take an equity position in AffyXell at a future funding round

Trending Articles

  1. Thermo Fisher Scientific reveals MagMax Sequential DNA/RNA Kit to advance blood cancer research The kit combines DNA and RNA isolation chemistries into a single kit, simplifying sample extraction for a broad range of downstream molecular applications
  2. CDMO market trends and dynamics The rise of the embedded model
  3. Medac and chiron develop organ-on chip tech for animal free drug testing The companies aim to develop an animal-free pharmaceutical testing method that utilises organ-on chip technology, and will be used in rheumatoid arthritis drug testing
  4. How iPSCs can bridge the translational gap in neuroscience Affecting more than one in three people, neurological disorders have a vast impact on global health while exacting a tremendous cost, reports Dr Max Mirza, Vice President of Neuroscience Drug Discovery at Sygnature Discovery
  5. Lonza At Lonza, we enable a healthier world by supporting our healthcare customers on the path to commercialization. Our community of around 17,500 skilled employees work across a global network of more than 30 sites to deliver for our customers across the pharma, biotech and nutrition markets. <br> <br> By combining technological insight with world-class manufacturing, scientific expertise and process excellence, we help our customers to deliver new and innovative medicines that help treat a wide range of diseases.

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Research & Development

AffyXell expands partnership with GenScript ProBio

As part of the strategic alliance, GenScript has committed to take an equity position in AffyXell at a future funding round
Ingredients

Affibody announces diabetes option exercise by Daewoong

Affibody will receive a license conversion fee and milestone payments as well as royalties. Further financial details were not disclosed.
Research & Development

Thermo Fisher Scientific reveals MagMax Sequential DNA/RNA Kit to advance blood cancer research

The kit combines DNA and RNA isolation chemistries into a single kit, simplifying sample extraction for a broad range of downstream molecular applications
Manufacturing

Precise and efficient VARIO diaphragm pumps from Vacuubrand

Advanced vacuum control for reproducible processes
Manufacturing

Isopod rapid cleanrooms helping life science start-ups and smaller businesses grow

The Guardtech Group’s quick-assembly pods provide a fast, high-quality cleanroom solution
Regulatory

Asahi Kasei Pharma grows its global portfolio with anti-CX3CR1 license

The licensing deal with Chiome enhances its open innovation platform
Sustainability

SPT Labtech integrates barcode scanner with elabnext platform

New tool boosts sample tracking and data integrity in life science labs
Subscribe now